The Advanced Therapy Medicinal Products CDMO Market is positioned for remarkable expansion, projected to escalate from a market size of USD 29.97 billion in 2024 to USD 134.73 billion by 2035. This represents a compound annual growth rate (CAGR) of 14.64%, underscoring the increasing significance of contract development and manufacturing organizations (CDMOs) in the biopharmaceutical sector. As...

The global Medical Device Contract Development and Manufacturing Organization (CDMO) market was valued at USD 134.7 billion in 2025 and is projected to grow from USD 148.8 billion in 2026 to USD 352.6 billion by 2033, registering a CAGR of 13.1% from 2026 to 2033. North America dominated the market with a revenue share of 48.8% in 2025, reflecting the region’s strong medical...

The global Small Molecule API Market was valued at USD 214.2 billion in 2024 and is projected to reach USD 297.0 billion by 2030, expanding at a CAGR of 5.6% from 2025 to 2030. Market growth is being driven by the rising prevalence of chronic diseases, increasing demand for small-molecule therapeutics, growing pharmaceutical R&D investments, and the continued expansion of...

The global Small Molecule Innovator API CDMO market was valued at USD 26.7 billion in 2025 and is projected to grow from USD 28.1 billion in 2026 to USD 43.7 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. Asia Pacific accounted for the largest 41.9% revenue share in 2025, supported by expanding pharmaceutical manufacturing capabilities, cost-efficient production...

The United States remains a dominant force in the 2D Chromatography Market, driven by its advanced pharmaceutical and biotechnology sectors, robust research infrastructure, and strong investment in analytical technologies. The country is home to numerous leading pharmaceutical manufacturers, contract research organizations, academic research institutions, and biotechnology companies that rely...

The global Viral Vaccine Cell Culture Media Market is experiencing a massive wave of transformation as pharmaceutical companies and research institutions shift toward advanced biological solutions. The rising prevalence of viral diseases, coupled with a renewed global focus on pandemic preparedness and annual immunization drives, has propelled the demand for high-quality cell culture media....

The Biopharmaceutical Fermentation Systems Market is witnessing steady expansion as pharmaceutical and biotechnology companies increasingly invest in advanced biologics manufacturing technologies. Fermentation systems play a crucial role in producing vaccines, monoclonal antibodies, recombinant proteins, cell therapies, and other biologic products. The growing demand for biologics, coupled with...

The Downstream Processing Market is experiencing remarkable growth as the global biopharmaceutical industry continues to expand and demand efficient purification and recovery solutions. Downstream processing plays a critical role in biotechnology and pharmaceutical manufacturing by separating, purifying, and formulating biological products such as vaccines, therapeutic proteins, monoclonal...

According to a new report from Intel Market Research, the Europe BFS (Blow‑Fill‑Seal) Products market was valued at USD 2.01 billion in 2024 and is projected to grow from USD 2.24 billion in 2025 to USD 4.37 billion by 2032, exhibiting a robust CAGR of 11.5% during the forecast period (2025–2032). This expansion is driven by the continent’s mature pharmaceutical ecosystem, stringent...

Global (S)-1-(3-Chlorophenyl)-ethylamine (CAS 68297-62-1) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 54.7 million by 2034, exhibiting a CAGR of 6.9% during the forecast period. (S)-1-(3-Chlorophenyl)-ethylamine is a chiral amine compound characterized by a single stereocenter bearing an amino group on a...